Amir Nashat

Amir Nashat (board member) discloses dealings in 9 companies, chiefly Fate Therapeutics Inc, Scholar Rock Holding Corp and Cartesian Therapeutics, Inc. The record holds 255 filings, for trades running from 14 May 2013 to 11 September 2025.

Both buying and selling appear: 26 purchases worth €35.6M, against 124 sales worth €47.1M. Taken together, the sales exceed the purchases by €11.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €230k. 14 out of 20 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 67% of cases, with a median move of +23.6%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 11 September 2025 with an open-market purchase (€111k) in Camp4 Therapeutics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.